Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform
Am J Respir Cell Mol Biol
.
2022 May;66(5):580-581.
doi: 10.1165/rcmb.2021-0369LE.
Authors
Claudia Mickael
1
,
Vitaly O Kheyfets
1
,
Christophe Langouët-Astrié
1
,
Michael H Lee
2
,
Linda A Sanders
1
,
Caio O Trentin
1
,
Andrew J Sweatt
3
,
Roham T Zamanian
3
,
Todd M Bull
1
,
Kurt Stenmark
1
,
Brian B Graham
2
,
Rubin M Tuder
1
Affiliations
1
University of Colorado Denver Aurora, Colorado.
2
University of California, San Francisco San Francisco, California.
3
Stanford University Stanford, California.
PMID:
35486078
PMCID:
PMC9116364
DOI:
10.1165/rcmb.2021-0369LE
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Familial Primary Pulmonary Hypertension
Humans
Inflammation
Proteomics
Pulmonary Arterial Hypertension*
Grants and funding
K25HL33481/HL/NHLBI NIH HHS/United States
P01HL152961/HL/NHLBI NIH HHS/United States
R56 HL152250/HL/NHLBI NIH HHS/United States
R01 HL152250/HL/NHLBI NIH HHS/United States
R01HL135872/HL/NHLBI NIH HHS/United States
P01 HL108797/HL/NHLBI NIH HHS/United States
K25 HL133481/HL/NHLBI NIH HHS/United States
T32 GM007635/GM/NIGMS NIH HHS/United States
R25 HL146166/HL/NHLBI NIH HHS/United States
K23 HL151892/HL/NHLBI NIH HHS/United States
P01 HL152961/HL/NHLBI NIH HHS/United States
R01 HL135872/HL/NHLBI NIH HHS/United States